-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IZVVGg+wdX2yB3sZSf7bM5d3Un8ZF7Ce94HkKdePKSbKJSn69Ww997xy3zDKuYbF EUHX1pDQb+2ma2a5SM5ZTQ== 0000875320-08-000034.txt : 20080528 0000875320-08-000034.hdr.sgml : 20080528 20080528135803 ACCESSION NUMBER: 0000875320-08-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080527 FILED AS OF DATE: 20080528 DATE AS OF CHANGE: 20080528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRIMBLECOMBE ROGER W CENTRAL INDEX KEY: 0001197034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08863094 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-27 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197034 BRIMBLECOMBE ROGER W C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2008-05-27 4 M 0 3333 14.20 A 3333 D Common Stock 2008-05-27 4 S 0 333 26.40 D 3000 D Common Stock 2008-05-27 4 S 0 334 26.54 D 2666 D Common Stock 2008-05-27 4 S 0 334 26.66 D 2332 D Common Stock 2008-05-27 4 S 0 666 26.68 D 1666 D Common Stock 2008-05-27 4 S 0 333 26.71 D 1333 D Common Stock 2008-05-27 4 S 0 333 26.75 D 1000 D Common Stock 2008-05-27 4 S 0 334 26.84 D 666 D Common Stock 2008-05-27 4 S 0 333 26.99 D 333 D Common Stock 2008-05-27 4 S 0 333 27.16 D 0 D Stock Option 14.20 2008-05-27 4 A 0 3333 0 D 1998-06-01 2008-05-31 Common Stock 3333 0 D Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1. Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998. Valerie L. Andrews, Attorney-In-Fact 2008-05-28 -----END PRIVACY-ENHANCED MESSAGE-----